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Abstract
Background: Nonsense-mediated decay is a mechanism that degrades mRNAs with a premature
termination codon. That some exons have premature termination codons at fixation is paradoxical:
why make a transcript if it is only to be destroyed? One model supposes that splicing is inherently
noisy and spurious transcripts are common. The evolution of a premature termination codon in a
regularly made unwanted transcript can be a means to prevent costly translation. Alternatively,
nonsense-mediated decay can be regulated under certain conditions so the presence of a
premature termination codon can be a means to up-regulate transcripts needed when nonsense-
mediated decay is suppressed.
Results: To resolve this issue we examined the properties of putative nonsense-mediated decay
targets in humans and mice. We started with a well-annotated set of protein coding genes and
found that 2 to 4% of genes are probably subject to nonsense-mediated decay, and that the
premature termination codon reflects neither rare mutations nor sequencing artefacts. Several
lines of evidence suggested that the noisy splicing model has considerable relevance: 1) exons that
are uniquely found in nonsense-mediated decay transcripts (nonsense-mediated decay-specific
exons) tend to be newly created; 2) have low-inclusion level; 3) tend not to be a multiple of three
long; 4) belong to genes with multiple splice isoforms more often than expected; and 5) these genes
are not obviously enriched for any functional class nor conserved as nonsense-mediated decay
candidates in other species. However, nonsense-mediated decay-specific exons for which distant
orthologous exons can be found tend to have been under purifying selection, consistent with the
regulation model.
Conclusion: We conclude that for recently evolved exons the noisy splicing model is the better
explanation of their properties, while for ancient exons the nonsense-mediated decay regulated
gene expression is a viable explanation.
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Background
Nonsense-mediated mRNA decay (NMD) is a mechanism
for rapid degradation of mRNA transcripts with premature
stop/termination codons (PTCs) [1-7]. Quite how a cell
knows that a stop codon is 'premature' is taxonomically
variable [2,4,8-12]. In Saccharomyces cerevisiae and Dro-
sophila melanogaster a termination codon is determined as
a PTC when positioned too far upstream of a poly(A) tail
[13-15]. In mammals, the species we consider here, the
recognition of premature termination codons generally
depends on the distance between nonsense codons and
the exon-exon junction closest to the 3' end. When this
distance is > 50 to 55 nucleotides, NMD is triggered and
the mRNA is degraded [1,16]. This is known as the NMD
55-nt rule (Figure 1) [16,17].
Note that the 55-nt rule will not capture all NMD subject
transcripts. Singh et al. found that an artificial 3' untrans-
lated region (UTR) of > 420 nucleotides can stimulate
NMD independent of the 55-nt rule [18]. Upstream open
The mammalian nonsense-mediated mRNA decay (NMD) rule Figure 1
The mammalian nonsense-mediated mRNA decay (NMD) rule. Stop codons located > 50 to 55 nucleotides upstream 
of the 3' most splice-generated exon-exon junction usually trigger NMD in mammals [16]. Mammalian genes are transcribed 
from the genome, which produces the precursor of mRNA (pre-mRNA). Pre-mRNA still contains exons (Ex) and introns (In), 
and is subject to processes including capping, polyadenylation and splicing. The splicing step removes the introns from pre-
mRNA and ligates the exons. The spliced mRNA then undergoes the first round of translation during export [17]. If the dis-
tance from the normal stop codon to the exon-exon junction closest to the 3'-end (labelled 'Distance' in the figure) is > 55 
nucleotides, in most cases the mRNA will be degraded by the NMD pathway – we refer to these transcripts as putative NMD 
targets. mRNAs for which the distance from the normal stop codon to the exon-exon junction closest to the 3'-end is < 50 to 
55 nucleotides are free of NMD decay. These mRNAs and ones with stop codons in the last exon are classified as putative 
non-NMD targets.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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reading frames (uORFs) can also trigger NMD in a size-
dependent manner [19]. Furthermore, cytoplasmic
poly(A)-binding protein (PABP) inhibits the interaction
between eRF3 and Upf1 in vitro and prevents NMD in cells
when positioned in proximity to the termination codon
[15,18-20]. Based on these findings, a unified model is
proposed that the distinction between translation termi-
nation at PTCs and at 'normal' termination codons relies
on the physical distance between the terminating ribos-
ome and PABP [21]. Nonetheless, the 55-nt rule is the best
defined and unlikely to greatly mislead.
That NMD is an important mechanism is witnessed by the
fact that the malfunction of NMD results in serious conse-
quences. In mice, loss of Rent1 (UPF1), a key factor of
NMD, leads to death at an early embryonic developmen-
tal stage [22]. Moreover, approximately one-third of
inherited genetic disorders and many forms of cancers are
associated with mutant genes containing PTCs [23-26].
The fact of NMD raises numerous questions. How many
genes have transcripts subject to NMD? More particularly,
beyond the occasional rare allele, why do many genes
have PTCs? Their existence is at first sight paradoxical:
why do cells make a transcript only for it to be degraded?
Given that transcripts are degraded to a certain extent,
might NMD genes be subject to weaker purifying selection
and might their relative freedom to explore sequence
space ensure that they are hot-spots for further adaptive
changes? Here we define a set of RefSeq genes that are
likely to be subject to NMD so as to investigate the above
issues.
As regards the central paradox of NMD, two hypotheses
are prominent [27,28]. First, one can suppose that splic-
ing is an inherently error-prone process regularly throw-
ing up the same unwanted transcripts [29,30]. This being
so, NMD can degrade these non-functional transcripts
avoiding costly-to-make, potentially toxic, proteins. We
consider this the noisy or spurious transcript model. Sec-
ond, the NMD machinery need not always be operative
and can be regulated. It can, for example, be suppressed
under nutrient-limiting conditions [10]. Similarly, both
levels of RNPS1  (an exon junction component) and
hypoxia can modulate NMD intensity [31,32]. NMD
could then be a mechanism to permit up-regulation of
specific transcripts on suppression of NMD. This we dub
the regulation model.
These two models make numerous predictions about the
properties and evolution of NMD target genes and exons.
The spurious transcript model predicts that NMD genes
should have more than one splice isoform. The regulation
model need not predict the same. The noisy model would
predict that spurious exons that are not multiples of three
(and hence induce frameshifts) should be more likely to
provide the selective conditions favouring an in-frame
PTC to prevent translation [29]. The noisy model addi-
tionally predicts that the NMD-inducing exons should be
in rare transcripts and more common in recently evolved
exons. By contrast, the regulation model predicts that the
NMD-specific exons should be under purifying selection
and that the NMD regulation of orthologous genes be
conserved in relatively distant species.
Prior evidence can be given to support both models. As
regards the regulation model, up-regulation of enzymes
associated with amino acid biosynthesis on NMD inacti-
vation, for example, has been related to a feedback circuit
coupling low amino acid levels with inactivation of NMD
and hence increased translation rates of mRNAs associ-
ated with amino acid biosynthesis [10]. More interest-
ingly, it has been reported that NMD is coupled with
alternative splicing to regulate a variety of genes [28]. For
instance, ribosomal mRNAs (for example rpL3,  rpL12)
[33,34] and splicing-related factors (for example, SC35,
PTB) [35-37] are auto-regulated by NMD and alternative
splicing. Related to this finding, tens of conserved stop-
containing exons whose inclusion renders the transcript
sensitive to NMD are found in mice, and these exons are
unusually frequent in genes that encode splicing activa-
tors (such as serine/arginine-rich proteins) and are unex-
pectedly enriched in the so-called 'ultraconserved'
elements in the mammalian lineage [38].
Other evidence supports the noisy splice model. Several
studies have made efforts to identify and study the natu-
rally occurring transcripts regulated by NMD [9-11,39-
42]. By aligning expressed sequence tags (ESTs) on
genomic regions to infer splicing isoforms, about 35% of
alternative splicing events are predicted to have the poten-
tial to produce PTC-containing transcripts [40,42]. Using
a similar method, Baek and Green also found that about
20% of conserved alternative splicing events produced
PTCs [43]. Based on the full-length transcripts, Xing and
Lee found that 11% of alternatively spliced isoforms con-
tained PTCs [44]. Using an alternative splicing microarray
platform Pan and co-workers found that most of the PTC-
containing transcripts were low in abundance across
examined tissues, and this low abundance was independ-
ent of NMD function [41], arguing against the regulation
function of NMD. Furthermore, comparative analysis
shows that NMD-inducing alternative splicing events are
not conserved between humans and mice [41] suggesting
noise above regulation, as does the finding that compari-
son of experimentally identified S. cerevisiae,  D. mela-
nogaster and human NMD putative targets showed that
most NMD candidates were not orthologous among these
species [4]. As a possible alternative explanation for the
latter finding is the existence of different PTC-recognitionBMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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mechanisms in each species [4], here we consider two spe-
cies with the same PTC-recognition mechanism, namely
mouse and human.
Based on RefSeq mRNAs of high quality, we systemati-
cally and computationally identify NMD candidates in
both species, according to the well-defined mammalian
NMD 55-nt rule [16] (Figure 1) and employ this set to
attempt to distinguish the noisy splicing from the regula-
tion model. We start by defining the data set, ensuring
that PTCs are not rare alleles or sequencing artefacts. We
then consider the functional and evolutionary properties
of NMD candidates. We find that NMD candidates are not
commonly conserved between humans and mice. NMD-
specific exons are rich in young and low-inclusion-level
exons. Although the NMD-specific exons have a high ratio
of non-synonymous (Ka) to synonymous (Ks) substitu-
tion rate, neutral evolution can be rejected. We find no
significant enrichment of NMD candidates in the class of
genes subject to positive selection.
Results
Two to four percent of RefSeq genes are nonsense-
mediated decay candidates and not explained as rare 
alleles or sequencing artefacts
NMD candidates were identified in human and mouse
from the RefSeq mRNA databases [45,46]. The RefSeq
database contains many partially manually curated
mRNA sequences, especially for those prefixed with
'NM_', which generally have experimental support. Based
on these 'NM_'-prefixed mRNAs and following the NMD
55-nt rule [16], we identified 701 and 498 NMD candi-
date genes in human and mouse, respectively (Table 1).
These represent 3.9% and 2.8% of genes examined in
human and mouse, respectively. The proportions are at
the lower boundary of previous reports [4,9-12]. This may
in part reflect the exclusion of many splicing isoforms,
owing to a lack of adequate experimental support, in the
RefSeq database [47]. On the other hand, previously
reported proportions of regulated genes were mostly
based on modulation of expression profiles and should
reflect both the direct and indirect effects of NMD
[31,39,48]. A priori such methods are expected to overes-
timate the number of genuine NMD targets [37].
By reference to the Mammalian Gene Collection full
length cDNAs [49,50] and dbSNP [51] data (Table S1 in
Additional file 1), we find that the NMD candidates have
the same quality support as other genes, indicating that
these candidates are not the result of sequence artefacts or
rare alleles. We also found that human NMD candidates
here are enriched for NMD potential targets, previously
determined in the study by Mendell et al [10] (Table S2 in
Additional file 1). As shown in Table 1, NMD candidates
generally encode shorter proteins and longer introns and
UTRs compared with non-NMD genes.
Few genes are nonsense-mediated decay candidates in 
both mouse and human
The splicing noise model predicts that an NMD gene in
one species need not be the target of NMD in another. The
regulation model does not necessarily predict this. Based
on the ortholog pairs identified with the Inparanoid pro-
gram [52], we counted the number of ortholog pairs that
were NMD candidates in both species (Table 2). Only 24
ortholog pairs (6.70% and 8.22% of human and mouse
NMD candidates, respectively) were NMD candidates in
both species (see the Additional file 2 for complete list of
conserved NMD candidates).
As it is likely that some NMD transcripts were missed from
the analysis due to strict data selection, we repeated the
analysis using all the RefSeq mRNAs, including predicted
mRNAs (with prefix 'XM_'). The number of NMD candi-
dates in both genomes increased as expected in this sec-
ond round. However, the intersection between NMD
orthologs was still small (see Table S3 in Additional file
1). The result is consistent with a previous comparison of
Table 1: Comparison of the gene structures of mouse and human nonsense-mediated mRNA decay and non-nonsense-mediated 
mRNA decay candidates
Human Mouse
NMD Non-NMD P NMD Non-NMD P
Average intron length 3,001 2,641.2 1.1 × 10-3 2,399.1 1,957.1 2.1 × 10-5
5' UTR length 145 132 8.4 × 10-4 124 102 7.0 × 10-6
3' UTR length 1,049 618 2.9 × 10-28 1134 513 4.4 × 10-47
Protein length 341 420 5.6 × 10-12 337 378 1.6 × 10-6
Total number of genes 701 17,498 498 17,479
Notes. NMD = Nonsense-mediated mRNA decay. NMD: NMD candidates; Non-NMD: genes that are not NMD candidates. The median values for 
each parameter are listed because the mean values were not suitable for highly skewed distributions. The P value was determined using the 
Wilcoxon rank-sum (Mann-Whitney) test.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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human, fruitfly D. melanogaster and S. cerevisiae NMD can-
didates [4,9-12]. We can also show that low rates of NMD
conservation are not consistent with the normal rates of
stop-codon turnover (see Table S4 in Additional file 1).
Our finding shows that, even when the mechanism of
PTC regulation is not a variable, deterministic regulation
by NMD is generally not selectively favoured over the long
term or is not the correct explanation for most PTCs.
Nonsense-mediated decay exons tend not to be multiples 
of three long
If an exon is included by noisy splicing, pressure not to be
translated should be higher if the exon is not a multiple of
three long than if it is a multiple of three long. The inclu-
sion of such exons will induce a frame shift if translated,
which will change the encoded amino acids downstream
of included exons. If so, this will result in proteins that are
at best costly to make and non-functional, and at worst
are toxic to cells. In contrast, inclusion of an exon that is a
multiple of three will typically result in a small peptide
insert but need not disrupt the overall function of that
protein. The costs of noisy splicing can be reduced to
some extent by degradation of these noisy transcripts
employing mRNA decay systems, such as by NMD. As
exons that are not a multiple of three impose a higher
cost, we expect stronger selection for PTCs in exons that
are not multiples of three compared with those that do
not induce frameshifts, assuming an equal rate of mis-
splicing. The regulation model makes no prediction of
bias.
We classified exons in NMD candidates as NMD-specific
exons (the exons observed only in NMD transcripts) and
NMD-nonspecific exons (the left exons in NMD candidate
genes) (Table 3). We began with genes having at least two
RefSeq mRNAs and obtained 36,643 internal coding
exons from 3,362 genes (including 252 NMD candidates
and 3,110 non-NMD genes) (Table 3). Among these, we
identified 278 NMD-specific exons and 2,353 NMD-non-
specific exons. Since NMD-specific exons may tend to be
owned by only one transcript, for better comparison we
classified exons in non-NMD candidates as non-NMD-
single (exons observed only in one RefSeq mRNA) and
non-NMD-multiple exons (the remaining exons in non-
NMD candidate genes) (Table 3). We focused on the
NMD-specific exons of cassette type, because these exons
did not overlap with regions in non-NMD transcripts and
were more suitable for our purpose.
As shown in the fourth column of Table 3, the lengths of
NMD-specific cassette exons are not divisible by three in
more cases (60.3%) than non-NMD cassette exons
(52.7% and 49.1% for non-NMD-single and non-NMD-
multiple, respectively, chi-square test, P values: 0.09616
and 0.01388). This supports the noisy splice model. Note
too that human-mouse conserved NMD exons show less
of a tendency to not be multiples of three (14 of 23 =
60.8%) than NMD exons created after the mouse-human
split (7 of 9 = 78%), although sample sizes are too small
to make definitive conclusions (See Table 4 for conserved
exons).
Nonsense-mediated decay-specific exons tend to be in the 
low inclusion category and newly created
According to the noisy splice model, the NMD transcript
is an alternatively spliced unwanted transcript. The regu-
lation model does not require the NMD transcripts to be
alternatively spliced transcripts, nor, if they are, need they
be the minority form (the transcript isoform that consti-
tutes a small fraction (less than one third) of transcripts
from the same gene). Are then NMD genes more likely to
be alternatively spliced than random genes and are the
NMD transcript isoforms rare? To investigate this we
mapped our gene lists to Ensembl genes with BioMart
[53], and extracted the splicing isoform information from
the ASD database [54,55].
Table 2: Few genes are nonsense-mediated mRNA decay 
candidates both in humans and mice.
Human Mouse
Number of orthologs 13,120 13,120
NMD candidates in either species 358 292
NMD candidates in both species 24 24
NMD = nonsense-mediated mRNA decay
Table 3: Classification of human exon types based on RefSeq data
Exon class Constitutive Alternative (Non-cassette) Alternative (Cassette)c Total
NMD-specifica 0 142 136 [82] 278
NMD-non-specifica 1,599 282 472 [251] 2,353
NonNMD-singleb 0 1697 4,110 [2,165] 5,807
NonNMD-multipleb 25,236 651 2,318 [1,137] 28,205
Notes. NMD = nonsense-mediated mRNA decay. a the NMD-specific exons are only observed in NMD transcripts, and the left exons of NMD 
candidate genes are classified as NMD-nonspecific. b the NonNMD-single exons are the ones observed only in one transcript, and the left exons of 
Non-NMD candidates are called as NonNMD-multiple. c the numbers in the square brackets are the counts of cassette exons whose lengths are 
not divided exactly by three. Cassette exons are the alternative exons completely skipped or included in splicing isoforms.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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We find that 419 out of 458 and 271 out of 347 (for
humans and mice, respectively) NMD candidate genes
have at least two known splicing isoforms in ASD [54,55]
(Table 5). Generally, one NMD candidate gene may have
both NMD and non-NMD transcript variants. Compared
with randomly selected genes we find that NMD candidates
are more commonly subject to alternative splicing in
humans (P = 0.0007832). However, there is no difference
in mouse (P = 0.8705). This is probably caused by: 1) mis-
classifying some true NMD targets into non-NMD set in
mouse due to smaller number of 'NM_' prefixed RefSeq
mRNAs (19,083 and 23,839 RefSeq mRNAs in our dataset
for mice and humans, respectively); and 2) lower detection
rate of alternative splicing for mice (79%) than humans
(86%) in the ASD database [54,55]. Note too that Xing and
Lee found that in rodents NMD candidates are subject to
alternative splicing more commonly than expected [44].
As expected from the noisy splicing model we found that
a larger proportion of NMD-specific exons (48%) were
spliced in minor form (included in less than one third of
transcripts transcribed from this gene) compared with
non-NMD-single exons (26.1%) (Figure 2) (One-sided
Kolmogorov-Smirnov test, P = 0.02443). This is consist-
ent with previous reports that most putative NMD tran-
scripts are expressed in low abundance across examined
tissues [41] and with the finding that both in humans and
mice the minor transcript has a PTC more commonly than
the major form (11.1% versus 3.7%) [44].
Are NMD exons ancient or new? To explore this question,
we examined the exon creation and loss events for each
NMD-specific cassette exon. To obtain this information,
we started by mapping our exons to those from the ASAP2
and the VEEDB databases [56,57]. The VEEDB database
provides exon conservation information for each given
exon based on splice site conservation, this being
extracted from a 17-vertebrate UCSC multi-genome align-
ment [57]. Using this exon conservation data, we could
determine whether a given human exon is conserved or
absent in mouse and dog (outgroup). Unfortunately, only
a small portion of exons are mapped to the VEEDB data-
base [57]. As shown in Table 4, 9 out of 35 NMD-specific
exons were created after the human-mouse split. This pro-
Table 4: Comparison of exon creation/loss between human nonsense-mediated mRNA decay-specific and non nonsense-mediated 
mRNA decay-single exons
Evolutionary patterns Human (source) Mouse (target) Dog (outgroup) NMD-specific NonNMD-single
Conserved in target + + + 23 436
Conserved in target + + - 1 13
Lost in target + - + 2 38
Created in source + - - 9 66
Total 35 553
Notes. NMD = nonsense-mediated mRNA decay. +, The orthologous exon exists in this lineage; -, The orthologous exon is not observed in this 
lineage.
Table 5: Identification of alternatively spliced genes based on the 
ASD database
Human Mouse
AS Non-AS AS Non-AS
NMD 419 39 271 76
Non-NMD 12047 1987 9761 2656
Notes. NMD = nonsense-mediated mRNA decay. In each cell are the 
counts of genes for each category. AS: the genes have alternative 
splicing isoforms identified in ASD database [54]. Non-AS: these 
genes have only one transcript isoform for each. Chi-square test: P = 
0.0007832 and 0.8705 for human and mouse, respectively.
Exon inclusion levels in different classes of cassette exons Figure 2
Exon inclusion levels in different classes of cassette 
exons. The nonsense-mediated mRNA decay-specific exons 
are enriched in the minor-form (inclusion level < 33%) inclu-
sion category and depleted in the major-form (inclusion level 
> 67%) category.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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portion (25.7%) is significantly higher than that of non-
NMD-single class exons (11.9%) (Fisher's exact test, P =
0.0315) (see Additional file 2 for human NMD-specific
exons conserved in mice). When we compared humans
against Rhesus macaques (Macaca mulatta) with mice as
outgroup, the difference is more significant (Additional
file 1, Table S5, NMD-specific 21.2%, non-NMD-single
4.5%, P = 0.001139). These findings are consistent with
the fact that NMD-inducing exons are often not conserved
among species [41]. The exon loss rates are much smaller
and there was no difference between NMD and non-NMD
exons.
An association between new and alternatively spliced
exons can probably also account for the rapid turnover of
genes subject to NMD. Two types of species-specific alter-
native splicing events can be defined [58,59]. One type,
referred to as 'species-specific alternative splicing of con-
served exons', is represented by a conserved exon that is
alternatively spliced in one species but constitutively
spliced in the other species. The other type, referred to as
'genome-specific alternative splicing', is represented by an
alternative exon in one species which is not detectable in
the ortholog of the other species (see Figure Three in [41]
for diagrams). More than 41% of species-specific alterna-
tive splicing events of conserved exons and 61% genome-
specific alternative splicing events had the potential to
trigger NMD, while the NMD-inducing rate of conserved
alternative splicing events between human and mice was
much lower (< 31%) [41]. No matter which form it is,
both types cause NMD to occur more often in only one of
the two species than in both species, and can hence
explain to a considerable extent NMD status divergence.
Where an orthologous exon can be found, the nonsense-
mediated decay-specific exon is or was under purifying 
selection
Both models (noise and expression regulation) predict
that NMD exons may be under lower selective constraint
than non-NMD exons. However the noisy model predicts
neutral evolution for the NMD-specific exons (owing to
their not being translated) while the regulation model
predicts there to be purifying selection still operating. To
examine the evolution of NMD-specific exons, we con-
catenated the alignments of the NMD-specific cassette
exons based on human-mouse-dog CDS alignments and
calculated Ka/Ks ratios (ω) of non-synonymous substitu-
tion rate (Ka) to synonymous substitution rate (Ks) for
each lineage using the PAML package [60] under the free-
ratio branch model [61], which assumes that each lineage
evolved independently. As expected (Table 6), the Ka/Ks
ratio in human NMD-specific cassette exons is higher than
that in other regions of NMD candidates (0.3432 versus
0.2627). This is consistent with weaker negative selection
pressure on the NMD exons. It is also higher than the
ratios for the orthologous exon in other lineages (0.1082
and 0.0884 for mouse and dog, respectively).
Comparing alternative cassette exons with other parts of
the same gene may be an error-prone test as cassette exons
may generally have weaker evolutionary pressures due to
their exclusions in some splicing isoforms. Indeed, we
observe a higher Ka/Ks ratio in non-NMD-single class of
exons than that in other regions (Table 6). To exclude the
effect of this, we compared the NMD-specific Ka/Ks ratio
against non-NMD-single exons. A higher Ka/Ks ratio for
the NMD-specific class was still observed (Table 6, 0.3423
versus 0.2554).
While these results are consistent with the regulated
expression model, fuller interpretation of the results is
non-trivial. First, the ability to detect orthologous exons
predisposes to finding exons functioning in regulation.
Second, even if the spurious transcript model is correct for
the lineage with the stop, the null for Ka/Ks is not 1. Cru-
cial is when the exon was subject to NMD and what form
of selection operated prior to this. If the exon was subject
to NMD very recently, then most of the evolutionary his-
tory of the exon down the human lineage was not evolv-
ing in response to the presence of the stop. Only if the
exon was always spurious, unlikely given that this exon is
found in multiple distant taxa, would Ka/Ks  = 1 be
Table 6: Ka/Ks ratios comparison between human nonsense-mediated mRNA decay and Non-nonsense-mediated mRNA decay 
concatenated alignments.
NMD-specific
exon alignmenta
Remained region
in NMD alignmenta
Non-NMD-single
exon alignmentb
Remained region
in Non-NMD alignmentb
ω (Human) 0.3423 0.2627 0.2554 0.1668
ω(Mouse) 0.1082 0.2184 0.1835 0.128
ω(Dog) 0.0884 0.2509 0.2193 0.1676
Notes. NMD = nonsense-mediated mRNA decay. ω (Human), ω (Mouse) and ω (Dog) are the Ka/Ks ratios in human, mouse and dog lineages, 
respectively. a NMD-specific exon alignment was concatenated alignment from the human NMD-specific exon regions of human-mouse-dog three-
way CDS alignments, and the rest regions in the CDS alignments were concatenated together to construct the remained NMD alignment. b similar 
to the NMD-specific case, the human non-NMD-single exon regions of human-mouse-dog three-way CDS alignments were clipped out to 
construct the concatenated alignment, and the rest regions to construct the remained non-NMD alignment. See Methods for details.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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expected for the lineage in question. In short, by virtue of
the fact that we can find distant orthologous exons, we are
almost certainly biasing the data set to exons that have
been and possibly still are functional. Given that Ka/Ks < 1
we can be confident that for some of the time the exon has
not been spurious.
Nonsense-mediated decay candidates are fast evolving but 
not hot-spots for adaptive evolution
Faster evolution for NMD-specific exons and higher Ka/Ks
ratios for NMD candidates (even when controlling the
expression profiles) (Figure S1 and Table S6 in Additional
file 1) caused us to wonder whether the evolutionary
mode of these genes is purifying selection, neutral evolu-
tion or adaptive evolution. Since most NMD candidates
showed Ka/Ks < 1 (Figure S2 in Additional file 1), these
genes were under purifying selection as a whole. Consist-
ent with this, we found that the NMD-specific cassette
exons rejected the neutral evolution model (Ka/Ks = 1)
using a likelihood ratio test [61] (Table 7, P = 1.77 × 10-
8), although they were fast evolving compared with other
regions in NMD candidates (Table 6).
Given that NMD candidates evolve faster in their own lin-
eage than orthologs (relative rate test, Table S7 in Addi-
tional file 1), possibly owing to reduced selective
constraints, it is tempting to suppose that NMD genes and
exons are potentially given much more freedom to roam
sequence space than exons of, for example, house-keeping
genes. Might this predispose NMD genes to be hot-spots
for adaptive evolution?
We checked if there were any cases of relaxed selection or
positive selection for NMD candidates based on data from
a previous study [62], which used a sensitive method
(branch-site model in PAML [63,64]) to detect positive
selection sites in human and chimp genes. As shown in
Table 8, of 8,824 genes 104 genes were considered under
positive selection in the human lineage. Four of 254 NMD
candidates were detected as being candidates for positive
selected. This proportion (1.6%) is slightly higher than
that (1.2%) of non-NMD genes, but not statistically sig-
nificant (P  value = 0.5453). We find no evidence that
NMD candidates are under relaxed selection (Table S8 in
Additional file 1) for the 254 examined NMD candidates,
indicating that, like most other genes, they are under puri-
fying selection.
Under-representation of some functional classes of genes 
in the nonsense-mediated decay set is consistent with noisy 
splicing
The above results suggest that for modern exons the noisy
splicing model is appropriate. One result in this context is
curious. While a gene that is an NMD candidate is unlikely
to be an NMD candidate in other species, we do see that
some functional classes of genes are consistently under-rep-
resented as NMD candidates (Table 9 and Additional file 3)
and the proportion of NMD candidates within any given
gene ontology (GO) class is largely unaltered between
mouse and human (see Additional file 4). At first sight this
conservation of function and the skew in representation
looks like evidence for regulated splicing which predicts
that NMD regulation might be particular for certain types
of genes (for example, starvation or hypoxia-specific
genes). We, however, note that this skew is also potentially
consistent with the noisy splicing model, if there is a covar-
iance between gene classes and rates of alternative splicing.
To examine the skew we employed tools of PANTHER
database [65,66]. The biological processes with Bonfer-
roni-corrected P values < 0.1 in either species are listed in
Table 9. About half of the NMD candidates were classified
as Biological process unclassified. This was the only set
showing over-representation with the NMD class. The
only other classes showing significant deviation from
expected showed under-representation, these being
Developmental processes, Cell-surface receptor-mediated
signal transduction, Sensory perception, Signal transduc-
tion, Chemosensory perception, and Olfaction. The func-
tional distributions of NMD candidates in humans and
mice were quite similar. Of the top six most significant
GO terms from either species, five (Biological process
unclassified, Developmental processes, Sensory percep-
tion, Signal transduction, Chemosensory perception) also
appeared in the list of the most significant in the other
species (Table 9).
To further determine whether the divergence of orthology in
NMD candidates also led to functional divergence, we com-
pared the functional distributions of human and mouse
NMD candidates using the FatiGO web tool [67], which is
able to detect particular GO terms for which the two lists of
genes have different proportions of genes. For feasibility, the
GO terms for mouse genes were deduced from the corre-
sponding human orthologs. No significant GO terms were
Table 7: Test of neutral evolution for human nonsense-mediated mRNA decay-specific exons under branch model.
Model ω (Human) ω (Mouse) ω (Dog) Log-likelihood Number of parameters P value
Free-ratios 0.3423 0.1082 0.0884 -6947.6716 7
Free-ratios(fix) 1 0.0973 0.0732 -6963.5371 6 1.77E-08
Note: if the neutral evolution occurred in human lineage, then the log-likelihood should not change much after the ω is fixed at 1. Our data reject 
this neutral model with a significant difference.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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detected at any level (GO levels 3 to 9; see Additional file 4).
To exclude the effect of orthologs that are NMD candidates
in both species, we repeated the analysis after removing these
orthologs from either or both species. As before there was no
GO term showing a significant difference between mice and
humans in the regularity of NMD (data not shown). This
indicates that there is no functional class in which there are
significantly more or fewer human NMD candidates com-
pared against mouse NMD candidates.
These results suggest that NMD targets different genes in
the two species, but ones largely in the same functional
categories (Table 9 and Additional file 4). While superfi-
cially this looks like evidence for regulated splicing, if
alternatively spliced genes are more prone to incorrect
splicing, we expect, under the noisy splicing model, that
the NMD-under-represented functional classes will have
fewer alternatively spliced genes than other classes.
To test this, we extracted the genes associated with each
functional class in Table 9 (excluding the Biological process
unclassified class) for humans from the PANTHER data-
base [65,66]. Then, we compared the proportion of alter-
natively spliced genes in each class against the rest. As
shown in Table 10, in total 12,466 out of 14,492 (86%)
genes are alternatively spliced based on the ASD database
[54,55], while the proportions for classes Developmental
processes, Cell-surface receptor-mediated signal transduction,
Sensory perception, Signal transduction and  Chemosensory
perception  are significantly smaller. Repeating the same
analysis after removing all the NMD genes we find the
same result (Table 10). These results suggest that covaria-
tion of functional class with NMD is consistent with the
noisy splice model and different regularities of alternative
splicing.
Discussion
While NMD must play a role in preventing the translation
of rare alleles with premature stop codons [23], it is per-
haps surprising that 2 to 4% of our genes have a prema-
ture stop codon that is not just a rare allele (Table S1 in
Additional file 1). While it is likely that in some cases
(ancient exons) NMD functions in a regulatory mode, our
results more strongly support the noisy splicing model.
Many features are consistent with this: the rarity of genes
regulated by NMD in one species being regulated by NMD
in the other (controlling for PTC recognition mechanism)
(Table 2 and Table S3 in Additional file 1); the excess of
exons that are not multiples of three long (Table 3); the
association with alternative splicing (Table 5) and with
minor splice forms (Figure 2); and the excess of modern
exons associated with NMD (Table 4 and Table S5 in
Additional file 1). Conservation of the gene classes subject
to NMD (Table 9 and Additional file 4) is also consistent,
given that gene class and propensity for alternative splic-
ing covary (Table 10). These results are consistent with
previous studies and extend their findings.
Is our estimate of 2 to 4% of genes being subject to NMD
accurate? This estimate is on the lower bounds, compared
with prior approaches [9-12]. This likely reflects in part
both our conservative approach and a tendency for alterna-
tive methods to over-estimate. As regards the latter, previ-
ous studies based on EST data [40,42,43] or expression
microarrays [10] found higher proportions of NMD candi-
dates. However this may include some aberrant transcripts
due to noise in EST data [68]. More problematic is the pos-
sibility that, as candidates are identified based on expres-
Table 8: The frequency of positive selection in human genes is 
not correlated with nonsense-mediated mRNA decay status.
PS Non-PS Total
NMD 4 250 254
Non-NMD 100 8470 8570
Note. NMD = nonsense-mediated mRNA decay. The information on 
positive selection (PS) was downloaded from the supplementary data 
in study [62]. Fisher's exact test, P = 0.5453.
Table 9: Biological process analysis of nonsense-mediated mRNA decay candidates.
Human Mouse
Biological process terms All genes NMD genes P value All genes NMD genes P value
Biological process unclassified 6,172 327O 1.45 × 10-11 6080 244O 1.28 × 10-11
Developmental processes 1,908 43U 1.68 × 10-3 1867 32U 5.70 × 10-2
Cell-surface receptor-mediated signal transduction 1,513 30U 3.56 × 10-3 -- -
Sensory perception 465 5U 1.08 × 10-2 971 13U 7.10 × 10-2
Signal transduction 3,127 87U 1.44 × 10-2 3491 66U 8.75 × 10-3
Chemosensory perception 203 0 6.03 × 10-2 545 2U 5.14 × 10-3
Olfaction - - - 539 2U 8.14 × 10-3
Total number of genes 18,172 693 17939 491
Notes. NMD = nonsense-mediated mRNA decay. The biological processes with Bonferroni-corrected P values < 0.1 are listed; the complete result 
is presented in Additional file 3. O: biological process was over-represented in NMD candidates; U: biological process was under-represented in 
NMD candidates; symbol '-' indicates that the biological process exhibited a P value > 0.1 in this species, but not in the other species.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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sion profile changes after inhibition of NMD, many
indirect NMD targets are included [31,39] (for example,
those up-regulated by a protein made from an NMD-regu-
lated gene). There are, however, at least two reasons why
our study might be conservative. First, because the RefSeq
database excludes splice forms without enough experimen-
tal support, many true NMD targets may well be missed.
Further, in employing the NMD 55-nt rule (Figure 1) to
identify the NMD candidates, we may well miss transcripts
regulated in a different manner. Notably both extended
3'UTR and uORFs can trigger NMD to some extent [18,19].
Parenthetically, our identified NMD candidates show
longer 3'UTRs than non-NMD genes (Table 1). Given an
association between long 3'UTR and NMD, it is possible
that both long 3'UTRs and an exon junction complex
downstream of a PTC contribute to targeting. On balance
then our 2 to 4% figure is probably conservative. By equal
measure, our NMD sample should be relatively clean (that
is, low false positive rate). For this reason we suggest that
the results that we present are likely to be robust.
Is it likely that spurious splicing will explain most PTCs in
other organisms? Consider, for example, S. cerevisiae. Here
only 5% of genes have introns and alternative splice forms
seem relatively rare. A priori in such a genome regulated
expression is expected to be the dominant explanation.
Nonetheless, a noisy splicing model of some form may yet
be viable. In the yeast genome, more than 70% of
genomic regions are transcribed [69,70] and the richness
of the transcriptome is greater than expected. It is viable to
suppose that some fraction of these transcripts is spurious
and selection for PTCs, out of the normal reading frame,
is selected for. Less clear is how such a model might
explain an in-frame PTC in a protein coding gene where
the PTC is the unique stop codon in the gene.
Conclusion
We find good evidence consistent with the noisy splicing
model, especially in the case of recent exons. However, for
ancient exons with a PTC association with NMD regulated
regulation is a viable model.
Methods
Data collection
We downloaded the sequences and annotations for
human and mice from the NCBI RefSeq [46] database
(Build 36.1) in January 2007. To improve the confidence
of NMD candidate identification, we only extracted the
transcripts with initial letters 'NM_'. Based on these anno-
tations, for each transcript, we calculated the distance
from the stop codon to the exon-exon junction closest to
the 3' end. According to the NMD rule [3,4,16], we classi-
fied transcripts as NMD candidates if the distance was >
55 nucleotide bps. Then, we defined a gene as an NMD
candidate if it had at least one NMD candidate transcript.
All the remaining genes in the genome were classified as
non-NMD candidates.
The UTR length, average intron length and protein length
for each transcript were also calculated or extracted from
the annotations. For each gene with multiple transcript
variants, we collapsed these parameters into one by
choosing the splicing form with the longest protein and
calculating the means of transcript isoforms.
Exon type classification
We started from 3,362 genes with at least two RefSeq
mRNAs in our dataset, which included 252 NMD and
3,110 Non-NMD candidates. We only considered the cod-
ing exons in each transcript and excluded the two mar-
ginal 5' and 3' exons within each gene due to their general
incompleteness. For NMD candidates, we searched the
exon isoforms only observed in NMD transcripts and
defined these exons as NMD-specific exons, and defined
the remaining exons in NMD candidates as NMD-non-
specific exons. For non-NMD candidates, we classified
exons as non-NMD-single and non-NMD-multiple. The
former were observed in only one splicing transcript iso-
Table 10: Evidence that there are fewer alternatively spliced genes in nonsense-mediated mRNA decay under-represented functional 
classes in humans.
Alla Non-NMDb
Biological process terms Non-AS AS AS Proportion P value Non-AS AS AS proportion P value
Developmental processes 286 1,304 0.82 1.27E-06 283 1271 0.82 1.43E-06
Cell surface receptor mediated signal transduction 224 834 0.79 3.40E-12 221 811 0.79 5.19E-12
Sensory perception 44 170 0.79 0.00699 44 165 0.79 0.00543
Signal transduction 416 2,029 0.83 2.44E-06 409 1960 0.83 2.31E-06
Chemosensory perception 5 5 0.50 0.00726 5 5 0.50 0.00767
Total genes 2,026 12,466 0.86 1987 12,047 0.86
Notes. NMD = nonsense-mediated mRNA decay. a all the genes with alternative splicing information were used. b only the genes that are not NMD 
candidates were used.BMC Biology 2009, 7:23 http://www.biomedcentral.com/1741-7007/7/23
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form for a given gene and the latter were observed in at
least two different splicing transcript isoforms.
Mapping exons to ASAP2 database
Since the ASAP2 database gives the positions of exons on
human chromosomes [71] of NCBI build 35.1
[46,72,73], equivalent to UCSC hg17 [74-76], we mapped
the human exon set of RefSeq mRNAs to the ASAP2 data-
base [56] as follows: first, we converted the exon positions
on reference sequence contigs into those on chromo-
somes (NCBI build 36.1, UCSC hg18) using a Perl script.
Second, we used the UCSC [76] liftOver tool to convert
these positions into those on human NCBI build 35.1
(UCSC hg17). Finally, we compared these positions with
those in the ASAP2 database and retrieved the ASAP2
exons that exactly matched the RefSeq exon set. 95,029 of
209,222 RefSeq exons can be uniquely mapped to the
ASAP2 database. Based on these matched exons, we can
easily obtain the splicing state, inclusion levels, exon cre-
ation/loss from the ASAP2 and the VEEDB database tables
[56,57].
Construction of exon alignments for nonsense-mediated 
decay -specific exons and calculation of Ka/Ks
Given the NMD-specific cassette exon lists above, we
extracted the corresponding regions from human-mouse-
dog CDS alignments (built by a Clustal W, version 1.83
[77], see Additional file 1 for details) and concatenated
them together. The remained regions in these alignments
were also concatenated. These concatenations were input-
ted separately into PAML [60] package to calculate Ka/Ks
ratio for each lineage under the free ratio model [61]. The
alignments for non-NMD-single exons and remaining
parts were similarly extracted and inputted into PAML for
Ka/Ks calculations.
To see if the NMD-specific exons were under neutral evo-
lution, we fixed the Ka/Ks at one in the human NMD line-
age under free ratio model [61], and compared this with a
more general model (with Ka/Ks free) to test if the neutral
model could be rejected using likelihood ratio tests (cal-
culated in R [78]).
Gene ontology analysis
Comparisons of functional distributions of NMD candi-
dates between human and mouse were carried out using
the FatiGO program [67]. FatiGO implements the nested
inclusive analysis, in which the test is done recursively
until the deepest level in which significance is obtained
and only this last level is reported. In this way both varia-
bles, the efficiency of the test and the highest precision in
the term found, are optimized. The program computes a
Fisher's two-tail exact test to statistically define over- or
under-represented terms between two lists of genes, and
the original P values are corrected by a false discovery rate
approach [79].
The detection of over- or under- represented functional
entries for NMD candidates was done based on the PAN-
THER database [65,66]. The NMD candidate list was com-
pared with the all the genes used and the P values were
determined using a binomial test for each functional cat-
egory. The original P values were adjusted using a modi-
fied Bonferroni correction method, which accounted for
the nesting relationship among GO terms at different lev-
els to avoid too conservative corrections.
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